Article
Precision Stratification: Kinase Assay in Asian <i>LRRK2</i> Risk Carriers and Idiopathic Parkinson Disease
2025-09-25
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Importance</h4> LRRK2 kinase inhibition is one of the most promising therapeutic strategies in Parkinson’s disease (PD), yet understanding of kinase activity in the Asian-prevalent p.G2385R and p.R1628P variants, each affecting 5–10% of PD patients, remains limited. Development of patient stratification and target engagement markers applicable across global cohorts is an urgent priority. <h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 003327be-c3db-51a6-9f48-f52f624965cd
- DOI
- 10.1101/2025.09.23.25336067
